Veterinary Grade GS-441524 Injectable Solution 20mg 30mg Antiviral Injection 6ml 8ml for FIP Support in Cats

Veterinary Grade GS-441524 Injectable Solution 20mg 30mg Antiviral Injection 6ml 8ml for FIP Support in Cats

Product Description

High Purity GS-441524 Injectable Solution for Veterinary FIP Management and Antiviral Research Applications

Product Overview

GS-441524 is a widely researched antiviral nucleoside analog commonly used in feline antiviral applications. It works by interfering with viral RNA replication, helping reduce viral activity during infection-related processes. Due to its stable performance and consistent quality, it has become a popular option in veterinary FIP management programs.

Key Features

• High purity injectable formulation
• Stable and reliable production quality
• Multiple strength and vial options
• Suitable for subcutaneous injection
• Export-standard packaging available

Functional Advantages

GS-441524 mimics natural nucleosides and interrupts viral RNA synthesis during replication. This mechanism helps slow viral proliferation and supports immune response activity.

Advantages may include:

• Strong antiviral research potential
• Consistent formulation stability
• Flexible dosing options
• Widely used in feline-related applications

FIP Application

FIP is a serious feline disease associated with mutated feline coronavirus and may appear as wet or dry forms.

Common symptoms include:

• Fever and loss of appetite
• Weight loss and lethargy
• Breathing difficulty
• Neurological or ocular symptoms

GS-441524 is commonly used in feline antiviral support programs intended to help control disease progression.

Reference Dosage

• Wet FIP: 0.3 ml/kg + 0.1 ml
• Dry FIP: 0.4 ml/kg + 0.1 ml
• Ocular/Neurological Cases: 0.5 ml/kg + 0.1 ml
• Relapse Cases: 0.6 ml/kg + 0.1 ml

Note: Dosage should follow veterinary guidance.

Application Scenarios

• Veterinary clinics
• Animal hospitals
• Cat breeders
• Veterinary antiviral research
• Feline healthcare programs